M. W. Saif, “U.S. Food and Drug Administration Approves Paclitaxel Protein-Bound Particles (Abraxane®) in Combination with Gemcitabine as First-Line Treatment of Patients with Metastatic Pancreatic Cancer”, JOP. J Pancreas (Online), vol. 14, no. 6, pp. 686–688, Nov. 2013.